| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?
|
Monda, Vincenzo M.
|
|
|
11 |
Suppl 1 |
p. 1909-1914
|
artikel
|
| 2 |
A Coloured Pen Needle Education System Improves Insulin Site Rotation Habits: Results of a Randomized Study
|
Berard, Lori D.
|
|
|
11 |
Suppl 1 |
p. 2979-2991
|
artikel
|
| 3 |
A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study
|
Sonmez, Alper
|
|
|
11 |
Suppl 1 |
p. 1045-1059
|
artikel
|
| 4 |
Acute Complications of Diabetes Among Pilgrims During Hajj 2017: A Brief Report
|
Khogeer, Zikra
|
|
|
11 |
Suppl 1 |
p. 747-751
|
artikel
|
| 5 |
Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study
|
Papanas, Nikolaos
|
|
|
11 |
Suppl 1 |
p. 2887-2908
|
artikel
|
| 6 |
Adverse Changes in HbA1c, Body Weight and Insulin Use in People with Type 1 Diabetes Mellitus Following Dapagliflozin Discontinuation in the DEPICT Clinical Trial Programme
|
Gordon, Jason
|
|
|
11 |
Suppl 1 |
p. 1135-1146
|
artikel
|
| 7 |
A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
|
Fadini, Gian Paolo
|
|
|
11 |
Suppl 1 |
p. 423-436
|
artikel
|
| 8 |
ANDREW: A Multicenter, Prospective, Observational Study in Patients with Type 2 Diabetes on Persistent Treatment with Dulaglutide
|
Bossi, Antonio C.
|
|
|
11 |
Suppl 1 |
p. 2677-2690
|
artikel
|
| 9 |
Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes
|
Mueller, Luke
|
|
|
11 |
Suppl 1 |
p. 681-699
|
artikel
|
| 10 |
Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes
|
Mueller, Luke
|
|
|
11 |
Suppl 1 |
p. 681-699
|
artikel
|
| 11 |
A Practitioner’s Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel
|
Kalra, Sanjay
|
|
|
11 |
Suppl 1 |
p. 585-606
|
artikel
|
| 12 |
A Practitioner’s Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert Panel
|
Kalra, Sanjay
|
|
|
11 |
Suppl 1 |
p. 585-606
|
artikel
|
| 13 |
A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol
|
Matsubara, Masaki
|
|
|
11 |
Suppl 1 |
p. 2729-2737
|
artikel
|
| 14 |
A Real-World Observational Study Evaluating the Probability of Glycemic Control with Basal Insulin or Glucagon-Like Peptide-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes
|
Baxter, Mike
|
|
|
11 |
Suppl 1 |
p. 1481-1496
|
artikel
|
| 15 |
A Retrospective Study of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Diabetes After Transplantation
|
Thangavelu, Thiyagarajan
|
|
|
11 |
Suppl 1 |
p. 987-994
|
artikel
|
| 16 |
A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus
|
Kalra, Sanjay
|
|
|
11 |
Suppl 1 |
p. 1965-1982
|
artikel
|
| 17 |
Aspirin Versus Clopidogrel Monotherapy for the Secondary Prevention of Recurrent Cerebrovascular Attack Following Previous Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
|
Qin, Zu-Ye
|
|
|
11 |
Suppl 1 |
p. 1091-1101
|
artikel
|
| 18 |
Assessing Diabetes Distress and Sleep Quality in Young Adults with Type 1 Diabetes Using FreeStyle Libre: A Prospective Cohort Study
|
Al Hayek, Ayman A.
|
|
|
11 |
Suppl 1 |
p. 1551-1562
|
artikel
|
| 19 |
Association Between Fasting Blood Glucose and All-Cause Mortality in a Rural Chinese Population: 15-Year Follow-Up Cohort Study
|
Cheng, Nannan
|
|
|
11 |
Suppl 1 |
p. 2691-2701
|
artikel
|
| 20 |
Association of Hemoglobin A1c, 1,5-Anhydro-d-Glucitol and Glycated Albumin with Oxidative Stress in Type 2 Diabetes Mellitus Patients: A Cross-Sectional Study
|
Kohata, Yo
|
|
|
11 |
Suppl 1 |
p. 655-665
|
artikel
|
| 21 |
Association of One-Leg Standing Time with Discontinuation of Injectable Medications During Hospitalization Among Patients with Type 2 Diabetes
|
Sugimoto, Kazuhiro
|
|
|
11 |
Suppl 1 |
p. 1179-1190
|
artikel
|
| 22 |
Baseline Characteristics of Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: Findings from the J-DISCOVER Study
|
Katakami, Naoto
|
|
|
11 |
Suppl 1 |
p. 1563-1578
|
artikel
|
| 23 |
Bioequivalence of Ultra Rapid Lispro (URLi) U100 and U200 Formulations in Healthy Subjects
|
Linnebjerg, Helle
|
|
|
11 |
Suppl 1 |
p. 1709-1720
|
artikel
|
| 24 |
Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Obstructive Sleep Apnea and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
|
Wang, Hong
|
|
|
11 |
Suppl 1 |
p. 1795-1806
|
artikel
|
| 25 |
Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents
|
Boye, Kristina S.
|
|
|
11 |
Suppl 1 |
p. 1513-1525
|
artikel
|
| 26 |
Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review
|
Berezin, Alexander E.
|
|
|
11 |
Suppl 1 |
p. 1271-1291
|
artikel
|
| 27 |
Clinical Characteristics, Treatment, and Prognosis of Diabetic Foot Disease in Macao and Beijing: A Retrospective Study
|
Zhang, Yang
|
|
|
11 |
Suppl 1 |
p. 1119-1133
|
artikel
|
| 28 |
Clinical Efficacy of Quadruple Oral Therapy for Type 2 Diabetes in Real-World Practice: A Retrospective Observational Study
|
Cho, Yun Kyung
|
|
|
11 |
Suppl 1 |
p. 2029-2039
|
artikel
|
| 29 |
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study
|
Romera, Irene
|
|
|
11 |
Suppl 1 |
p. 437-451
|
artikel
|
| 30 |
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study
|
Romera, Irene
|
|
|
11 |
Suppl 1 |
p. 437-451
|
artikel
|
| 31 |
Clinical Outcomes of Switching to Insulin Glargine 300 U/ml from Other Basal Insulins in People with Type 2 Diabetes in Italy: A Real-World Study
|
Ragonese, Mauro
|
|
|
11 |
Suppl 1 |
p. 2283-2298
|
artikel
|
| 32 |
Comparison of Blood Glucose Variability Between Exenatide and Biphasic Insulin Aspart 30 in Chinese Participants with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A Multicenter, Open-Label, Randomized Trial
|
Wang, Li
|
|
|
11 |
Suppl 1 |
p. 2313-2328
|
artikel
|
| 33 |
Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
|
Lee, Jiwoo
|
|
|
11 |
Suppl 1 |
p. 859-871
|
artikel
|
| 34 |
Continuous Lumbar Sympathetic Blockade Enhances the Effect of Lumbar Sympatholysis on Refractory Diabetic Neuropathy: A Randomized Controlled Trial
|
Sun, Haiyan
|
|
|
11 |
Suppl 1 |
p. 2647-2655
|
artikel
|
| 35 |
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
|
Battelino, Tadej
|
|
|
11 |
Suppl 1 |
p. 1907-1908
|
artikel
|
| 36 |
Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
|
Battelino, Tadej
|
|
|
11 |
Suppl 1 |
p. 1607-1608
|
artikel
|
| 37 |
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
|
Evans, Marc
|
|
|
11 |
Suppl 1 |
p. 571
|
artikel
|
| 38 |
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
|
Evans, Marc
|
|
|
11 |
Suppl 1 |
p. 571
|
artikel
|
| 39 |
Correction to: Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
|
Guja, Cristian
|
|
|
11 |
Suppl 1 |
p. 3011-3013
|
artikel
|
| 40 |
Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial
|
Watada, Hirotaka
|
|
|
11 |
Suppl 1 |
p. 1721-1734
|
artikel
|
| 41 |
Diabetes and Novel Coronavirus Infection: Implications for Treatment
|
Williams, David M.
|
|
|
11 |
Suppl 1 |
p. 1915-1924
|
artikel
|
| 42 |
Diabetes Care During Hajj
|
Shaikh, Shehla
|
|
|
11 |
Suppl 1 |
p. 2829-2844
|
artikel
|
| 43 |
Diabetes Podcast: Do It Yourself/Open Source Artificial Pancreas Systems: Part 1
|
Hussain, Sufyan
|
|
|
11 |
Suppl 1 |
p. 1609-1619
|
artikel
|
| 44 |
Diabetes-Related Effectiveness and Cost of Liraglutide or Insulin in German Patients with Type 2 Diabetes: A 5-Year Retrospective Claims Analysis
|
Wilke, Thomas
|
|
|
11 |
Suppl 1 |
p. 2357-2370
|
artikel
|
| 45 |
Diabetic Neuropathy Collection: Progress in Diagnosis and Screening
|
Papanas, Nikolaos
|
|
|
11 |
Suppl 1 |
p. 761-764
|
artikel
|
| 46 |
Diabetic Neuropathy Collection: Treatment of Diabetic Neuropathy
|
Alam, Uazman
|
|
|
11 |
Suppl 1 |
p. 765-772
|
artikel
|
| 47 |
Discontinuing Aspirin After Short Term Use Versus Continuous Use with a P2Y12 Inhibitor for the Treatment of Patients with Type 2 Diabetes Mellitus Following Percutaneous Coronary Intervention: A Meta-analysis
|
Wang, Qiang
|
|
|
11 |
Suppl 1 |
p. 2299-2311
|
artikel
|
| 48 |
Disease Burden and Healthcare Costs for T2D Patients With and Without Established Cardiovascular Disease in Sweden: A Retrospective Cohort Study
|
Bernfort, Lars
|
|
|
11 |
Suppl 1 |
p. 1537-1549
|
artikel
|
| 49 |
Does Roux-en-Y Construction Really Bring Benefit of Type 2 Diabetes Mellitus Remission After Gastrectomy in Patients with Gastric Cancer? A Systematic Review and Meta-Analysis
|
Peng, Dong
|
|
|
11 |
Suppl 1 |
p. 2863-2872
|
artikel
|
| 50 |
Drug Therapy in Obesity: A Review of Current and Emerging Treatments
|
Williams, David M.
|
|
|
11 |
Suppl 1 |
p. 1199-1216
|
artikel
|
| 51 |
Early Combination Therapy with Linagliptin and Metformin in People with Type 2 Diabetes Improves Glycemic Control to HbA1c ≤ 6.5% without Increasing Hypoglycemia: Pooled Analysis of Two Randomized Clinical Trials
|
Lv, Qian
|
|
|
11 |
Suppl 1 |
p. 1317-1330
|
artikel
|
| 52 |
Effectiveness of a Video-Based Lifestyle Education Program Compared to Usual Care in Improving HbA1c and Other Metabolic Parameters in Individuals with Type 2 Diabetes: An Open-Label Parallel Arm Randomized Control Trial (RCT)
|
Gupta, Uttio
|
|
|
11 |
Suppl 1 |
p. 667-679
|
artikel
|
| 53 |
Effectiveness of a Video-Based Lifestyle Education Program Compared to Usual Care in Improving HbA1c and Other Metabolic Parameters in Individuals with Type 2 Diabetes: An Open-Label Parallel Arm Randomized Control Trial (RCT)
|
Gupta, Uttio
|
|
|
11 |
Suppl 1 |
p. 667-679
|
artikel
|
| 54 |
Effectiveness of the Freestyle Libre Flash Glucose Monitoring System on Diabetes Distress Among Individuals with Type 1 Diabetes: A Prospective Study
|
Al Hayek, Ayman A.
|
|
|
11 |
Suppl 1 |
p. 927-937
|
artikel
|
| 55 |
Effect of Sodium-Glucose Cotransporter-2 Inhibitors on Endothelial Function: A Systematic Review of Preclinical Studies
|
Alshnbari, Afnan S.
|
|
|
11 |
Suppl 1 |
p. 1947-1963
|
artikel
|
| 56 |
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
|
Gallo, Silvina
|
|
|
11 |
Suppl 1 |
p. 1849-1860
|
artikel
|
| 57 |
Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis
|
Yu, Miao
|
|
|
11 |
Suppl 1 |
p. 1147-1159
|
artikel
|
| 58 |
Efficacy and Safety of Dulaglutide Monotherapy Compared to Glimepiride in Oral Antihyperglycemic Medication-Naïve Chinese patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN1
|
Li, Yi Ming
|
|
|
11 |
Suppl 1 |
p. 1077-1090
|
artikel
|
| 59 |
Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis
|
Tabák, Ádám G.
|
|
|
11 |
Suppl 1 |
p. 305-318
|
artikel
|
| 60 |
Efficacy and Safety of Once-Weekly Dulaglutide in Elderly Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis of AWARD-CHN Studies
|
Kuang, Jian
|
|
|
11 |
Suppl 1 |
p. 2329-2339
|
artikel
|
| 61 |
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
|
Onishi, Yukiko
|
|
|
11 |
Suppl 1 |
p. 735-745
|
artikel
|
| 62 |
Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
|
Onishi, Yukiko
|
|
|
11 |
Suppl 1 |
p. 735-745
|
artikel
|
| 63 |
Efficacy and Safety of Tofogliflozin and Ipragliflozin for Patients with Type-2 Diabetes: A Randomized Crossover Study by Flash Glucose Monitoring
|
Kawaguchi, Yuji
|
|
|
11 |
Suppl 1 |
p. 2945-2958
|
artikel
|
| 64 |
Efficacy and Safety of Treatment with New Basal Insulin Analogues in Type 1 Diabetes: Nation-Wide Survey
|
Svensson, Ann-Marie
|
|
|
11 |
Suppl 1 |
p. 725-734
|
artikel
|
| 65 |
Efficacy and Safety of Treatment with New Basal Insulin Analogues in Type 1 Diabetes: Nation-Wide Survey
|
Svensson, Ann-Marie
|
|
|
11 |
Suppl 1 |
p. 725-734
|
artikel
|
| 66 |
Efficacy of Vildagliptin Added to Continuous Subcutaneous Insulin Infusion (CSII) in Hospitalized Patients with Type 2 Diabetes
|
Lyu, Fu-ping
|
|
|
11 |
Suppl 1 |
p. 701-710
|
artikel
|
| 67 |
EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China
|
Zhang, Yichen
|
|
|
11 |
Suppl 1 |
p. 939-950
|
artikel
|
| 68 |
Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials
|
Guo, Lixin
|
|
|
11 |
Suppl 1 |
p. 1821-1833
|
artikel
|
| 69 |
Evaluation of Glycaemic Control, Glucose Variability and Hypoglycaemia on Long-Term Continuous Subcutaneous Infusion vs. Multiple Daily Injections: Observational Study in Pregnancies With Pre-Existing Type 1 Diabetes
|
Jotic, Aleksandra
|
|
|
11 |
Suppl 1 |
p. 845-858
|
artikel
|
| 70 |
Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective
|
Haluzík, Martin
|
|
|
11 |
Suppl 1 |
p. 1029-1043
|
artikel
|
| 71 |
Familial Hypercholesterolaemia in a Bulgarian Population of Patients with Dyslipidaemia and Diabetes: An Observational Study
|
Tankova, Tsvetalina
|
|
|
11 |
Suppl 1 |
p. 453-465
|
artikel
|
| 72 |
Familial Hypercholesterolaemia in a Bulgarian Population of Patients with Dyslipidaemia and Diabetes: An Observational Study
|
Tankova, Tsvetalina
|
|
|
11 |
Suppl 1 |
p. 453-465
|
artikel
|
| 73 |
Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L
|
Blonde, Lawrence
|
|
|
11 |
Suppl 1 |
p. 1007-1015
|
artikel
|
| 74 |
GLP-1RAs and SGLT2is Reduce Cardiovascular Events Independent of Reductions of Systolic Blood Pressure and Body Weight: A Meta-Analysis with Meta-Regression
|
Qiu, Mei
|
|
|
11 |
Suppl 1 |
p. 2429-2440
|
artikel
|
| 75 |
Glucagon Administration by Nasal and Intramuscular Routes in Adults With Type 1 Diabetes During Insulin-Induced Hypoglycaemia: A Randomised, Open-Label, Crossover Study
|
Suico, Jeffrey G.
|
|
|
11 |
Suppl 1 |
p. 1591-1603
|
artikel
|
| 76 |
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy
|
Bonora, Benedetta Maria
|
|
|
11 |
Suppl 1 |
p. 1369-1379
|
artikel
|
| 77 |
Glycemic Control Among Patients Newly Prescribed IDegLira Across Prior Therapy Group in US Real-World Practice
|
Egede, Leonard E.
|
|
|
11 |
Suppl 1 |
p. 1579-1589
|
artikel
|
| 78 |
Glycemic Control and its Predictors among Adult Diabetic Patients attending Mettu Karl Referral Hospital, Southwest Ethiopia: A Prospective Observational Study
|
Sheleme, Tadesse
|
|
|
11 |
Suppl 1 |
p. 1775-1794
|
artikel
|
| 79 |
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study
|
Peng, Xuejun Victor
|
|
|
11 |
Suppl 1 |
p. 2629-2645
|
artikel
|
| 80 |
Hospitalization Costs Due to Hypoglycemia in Patients with Diabetes: A Microcosting Approach
|
Ferreira, João P.
|
|
|
11 |
Suppl 1 |
p. 2237-2255
|
artikel
|
| 81 |
IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy
|
Watada, Hirotaka
|
|
|
11 |
Suppl 1 |
p. 331-339
|
artikel
|
| 82 |
Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances
|
Peláez-Jaramillo, María J.
|
|
|
11 |
Suppl 1 |
p. 229-245
|
artikel
|
| 83 |
Impact of Liver Cirrhosis on Incidence of Dialysis Among Patients with Type 2 Diabetes
|
Sheen, Yi-Jing
|
|
|
11 |
Suppl 1 |
p. 2611-2628
|
artikel
|
| 84 |
Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study
|
Peng, Xuejun Victor
|
|
|
11 |
Suppl 1 |
p. 995-1005
|
artikel
|
| 85 |
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
|
Mathieu, Chantal
|
|
|
11 |
Suppl 1 |
p. 495-507
|
artikel
|
| 86 |
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
|
Mathieu, Chantal
|
|
|
11 |
Suppl 1 |
p. 495-507
|
artikel
|
| 87 |
Improved Framingham Risk Scores of Patients with Type 2 Diabetes Mellitus in the Beijing Community: A 10-Year Prospective Study of the Effects of Multifactorial Interventions on Cardiovascular Risk Factors (The Beijing Communities Diabetes Study 22)
|
Zhang, Xue-Lian
|
|
|
11 |
Suppl 1 |
p. 885-903
|
artikel
|
| 88 |
InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Study Design
|
Battelino, Tadej
|
|
|
11 |
Suppl 1 |
p. 1017-1027
|
artikel
|
| 89 |
Insights into the Role of Renal Biopsy in Patients with T2DM: A Literature Review of Global Renal Biopsy Results
|
Tong, Xue
|
|
|
11 |
Suppl 1 |
p. 1983-1999
|
artikel
|
| 90 |
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
|
Hidvégi, Tibor
|
|
|
11 |
Suppl 1 |
p. 467-478
|
artikel
|
| 91 |
Insulin Pump Therapy Issues Among Adults with Type 1 Diabetes Mellitus in Saudi Arabia: A Retrospective Study
|
Al-Saleh, Yousef
|
|
|
11 |
Suppl 1 |
p. 2993-3001
|
artikel
|
| 92 |
Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient’s Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data
|
Šimonienė, Diana
|
|
|
11 |
Suppl 1 |
p. 161-174
|
artikel
|
| 93 |
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
|
Janež, Andrej
|
|
|
11 |
Suppl 1 |
p. 387-409
|
artikel
|
| 94 |
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review
|
Janež, Andrej
|
|
|
11 |
Suppl 1 |
p. 387-409
|
artikel
|
| 95 |
INtegration of care for reaching targetS In Diabetic patiEnts: Design of the INSIDE Study
|
Comaschi, Marco
|
|
|
11 |
Suppl 1 |
p. 359-367
|
artikel
|
| 96 |
Intervention Delivery Matters: What Mothers at High Risk for Type 2 Diabetes Want in a Diabetes Prevention Program—Results from a Comparative Effectiveness Trial
|
Palmer, Kelly N. B.
|
|
|
11 |
Suppl 1 |
p. 2411-2418
|
artikel
|
| 97 |
Kidney Disease in Type 2 Diabetes Mellitus and Benefits of Sodium-Glucose Cotransporter 2 Inhibitors: A Consensus Statement
|
Roy, Ajitesh
|
|
|
11 |
Suppl 1 |
p. 2791-2827
|
artikel
|
| 98 |
Letter to the Editor Regarding: Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment
|
Iwahori, Toshiyuki
|
|
|
11 |
Suppl 1 |
p. 2441-2442
|
artikel
|
| 99 |
Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis
|
Men, Peng
|
|
|
11 |
Suppl 1 |
p. 1745-1755
|
artikel
|
| 100 |
Long-Term Cilostazol Treatment and Predictive Factors on Outcomes of Endovascular Intervention in Patients with Diabetes Mellitus and Critical Limb Ischemia
|
Lee, Chiu-Yang
|
|
|
11 |
Suppl 1 |
p. 1757-1773
|
artikel
|
| 101 |
Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK
|
Ramos, Mafalda
|
|
|
11 |
Suppl 1 |
p. 2041-2055
|
artikel
|
| 102 |
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study
|
Yamamoto, Fumiko
|
|
|
11 |
Suppl 1 |
p. 523-533
|
artikel
|
| 103 |
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes Mellitus: A 3-Year Post-Marketing Surveillance Study
|
Yamamoto, Fumiko
|
|
|
11 |
Suppl 1 |
p. 107-117
|
artikel
|
| 104 |
Looping with Do-It-Yourself Artificial Pancreas Systems During Ramadan Fasting in Type 1 Diabetes Mellitus: Perspectives of a User and a Physician
|
Ahmed, Syed Haris
|
|
|
11 |
Suppl 1 |
p. 2453-2463
|
artikel
|
| 105 |
Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes
|
Kovatchev, Boris
|
|
|
11 |
Suppl 1 |
p. 1293-1302
|
artikel
|
| 106 |
Measurement Uncertainty Impacts Diagnosis of Diabetes Mellitus: Reliable Minimal Difference of Plasma Glucose Results
|
Keutmann, Sandra
|
|
|
11 |
Suppl 1 |
p. 293-303
|
artikel
|
| 107 |
Metabolic Control and Adherence to Therapy in Type 2 Diabetes Mellitus Patients Using IDegLira in a Real-World Setting
|
Melzer-Cohen, Cheli
|
|
|
11 |
Suppl 1 |
p. 185-196
|
artikel
|
| 108 |
Metformin Delays the Development of Atherosclerosis in Type 1 Diabetes Mellitus via the Methylglyoxal Pathway
|
Liu, Aihong
|
|
|
11 |
Suppl 1 |
p. 633-642
|
artikel
|
| 109 |
Metformin Delays the Development of Atherosclerosis in Type 1 Diabetes Mellitus via the Methylglyoxal Pathway
|
Liu, Aihong
|
|
|
11 |
Suppl 1 |
p. 633-642
|
artikel
|
| 110 |
Methodological Tools for Exploring Novel Biopharmaceutical Approaches to the Metabolic Syndrome and Related Disorders
|
Lonardo, Amedeo
|
|
|
11 |
Suppl 1 |
p. 773-777
|
artikel
|
| 111 |
Model-based Prediction of the Long-term Glucose-Lowering Effects of Ipragliflozin, a Selective Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor, in Patients with Type 2 Diabetes Mellitus
|
Saito, Masako
|
|
|
11 |
Suppl 1 |
p. 951-964
|
artikel
|
| 112 |
Nationwide Survey on Actual Interventions for Type 2 Diabetes by Japanese Practitioners (NSAID Study-1): Glycemic, Weight, and Blood Pressure Management
|
Arai, Keiko
|
|
|
11 |
Suppl 1 |
p. 1497-1511
|
artikel
|
| 113 |
Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study
|
Ishii, Hitoshi
|
|
|
11 |
Suppl 1 |
p. 133-145
|
artikel
|
| 114 |
Once-Weekly Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Common OAD: a Subgroup Analysis from SUSTAIN 2–4 and 10
|
Capehorn, Matthew
|
|
|
11 |
Suppl 1 |
p. 1061-1075
|
artikel
|
| 115 |
One-Year Effectiveness Study of Intravitreously Administered Conbercept® Monotherapy in Diabetic Macular Degeneration: A Systematic Review and Meta-Analysis
|
Wang, Heping
|
|
|
11 |
Suppl 1 |
p. 1103-1117
|
artikel
|
| 116 |
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes
|
Evans, Marc
|
|
|
11 |
Suppl 1 |
p. 37-52
|
artikel
|
| 117 |
Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme
|
Bain, Stephen C.
|
|
|
11 |
Suppl 1 |
p. 259-277
|
artikel
|
| 118 |
Patient Preferences and Health State Utilities Associated with Mealtime Insulin Concentrations Among Patients with Diabetes in Italy
|
Matza, Louis S.
|
|
|
11 |
Suppl 1 |
p. 319-330
|
artikel
|
| 119 |
Patient Satisfaction and Clinical Efficacy of Flash Glucose Monitoring in Patients with Type 1 Diabetes: A Prospective, Single-Center, Single-Arm Study
|
Ueno, Keisuke
|
|
|
11 |
Suppl 1 |
p. 1883-1890
|
artikel
|
| 120 |
Periodontal Disease in Diabetes Mellitus: A Case–Control Study in Smokers and Non-Smokers
|
Battancs, Emese
|
|
|
11 |
Suppl 1 |
p. 2715-2728
|
artikel
|
| 121 |
Persistence with Basal Insulin and Frequency of Hypoglycemia Requiring Hospitalization in Patients with Type 2 Diabetes
|
Roussel, Ronan
|
|
|
11 |
Suppl 1 |
p. 1861-1872
|
artikel
|
| 122 |
Persistence with IDegLira in Patients in Clinical Practice: A Nationwide Observational Study in Sweden
|
Eliasson, Björn
|
|
|
11 |
Suppl 1 |
p. 1807-1820
|
artikel
|
| 123 |
Pre-Gestational Diabetes and Pregnancy Outcomes
|
Ali, Dalal S.
|
|
|
11 |
Suppl 1 |
p. 2873-2885
|
artikel
|
| 124 |
Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study
|
Giorda, Carlo Bruno
|
|
|
11 |
Suppl 1 |
p. 2105-2119
|
artikel
|
| 125 |
Quality of Life and Utility Values for Cost-Effectiveness Modeling in Japanese Patients with Type 2 Diabetes
|
Ishii, Hitoshi
|
|
|
11 |
Suppl 1 |
p. 2931-2943
|
artikel
|
| 126 |
Ramadan and Diabetes: A Narrative Review and Practice Update
|
Ahmed, Syed H.
|
|
|
11 |
Suppl 1 |
p. 2477-2520
|
artikel
|
| 127 |
Ranibizumab Pretreatment in Vitrectomy with Internal Limiting Membrane Peeling on Diabetic Macular Edema in Severe Proliferative Diabetic Retinopathy
|
Guan, Jian
|
|
|
11 |
Suppl 1 |
p. 1397-1406
|
artikel
|
| 128 |
Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update
|
Hanefeld, Markolf
|
|
|
11 |
Suppl 1 |
p. 1645-1666
|
artikel
|
| 129 |
Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
|
Robinson, Susan
|
|
|
11 |
Suppl 1 |
p. 1437-1466
|
artikel
|
| 130 |
Real-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospective Observational Study
|
Dang-Tan, Tam
|
|
|
11 |
Suppl 1 |
p. 213-228
|
artikel
|
| 131 |
Recreational Cannabis Usage Among Young Adults Living with Diabetes: Protocol for a Mixed Methods Study
|
Ibrahim, Sarah
|
|
|
11 |
Suppl 1 |
p. 1407-1417
|
artikel
|
| 132 |
Reduced Rates of Hypoglycemia in Type 1 or Type 2 Diabetes After Switching to Insulin Degludec: Results from the Italian Cohort of the ReFLeCT Study
|
Fadini, Gian Paolo
|
|
|
11 |
Suppl 1 |
p. 2909-2920
|
artikel
|
| 133 |
Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis
|
Shamanna, Paramesh
|
|
|
11 |
Suppl 1 |
p. 2703-2714
|
artikel
|
| 134 |
Relationship Between Estimated Glycosylated Hemoglobin Using Flash Glucose Monitoring and Actual Measured Glycosylated Hemoglobin in a Chinese Population
|
Hu, Yun
|
|
|
11 |
Suppl 1 |
p. 2019-2027
|
artikel
|
| 135 |
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
|
Williams, David M.
|
|
|
11 |
Suppl 1 |
p. 369-386
|
artikel
|
| 136 |
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
|
Williams, David M.
|
|
|
11 |
Suppl 1 |
p. 369-386
|
artikel
|
| 137 |
Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”
|
Brooks, Anne B.
|
|
|
11 |
Suppl 1 |
p. 2443-2446
|
artikel
|
| 138 |
Risk Factors of Ketosis in Obese Ketosis-Prone Diabetic Patients: A Case-Control Study
|
Shi, Li
|
|
|
11 |
Suppl 1 |
p. 965-977
|
artikel
|
| 139 |
Role of Gliclazide MR in the Management of Type 2 Diabetes: Report of a Symposium on Real-World Evidence and New Perspectives
|
Khunti, Kamlesh
|
|
|
11 |
Suppl 1 |
p. 33-48
|
artikel
|
| 140 |
Safety and Efficacy of Exenatide Once Weekly in Participants with Type 2 Diabetes and Stage 2/3 Chronic Kidney Disease
|
Guja, Cristian
|
|
|
11 |
Suppl 1 |
p. 1467-1480
|
artikel
|
| 141 |
Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials
|
Patel, Shrita
|
|
|
11 |
Suppl 1 |
p. 1347-1367
|
artikel
|
| 142 |
Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
|
Williams, David M.
|
|
|
11 |
Suppl 1 |
p. 2221-2235
|
artikel
|
| 143 |
SGLT2 Inhibitors and the Risk of Hospitalization for Fournier’s Gangrene: A Nested Case–Control Study
|
Wang, Tongtong
|
|
|
11 |
Suppl 1 |
p. 711-723
|
artikel
|
| 144 |
Social Inequality and Diabetes: A Commentary
|
Barnard-Kelly, Katharine D.
|
|
|
11 |
Suppl 1 |
p. 803-811
|
artikel
|
| 145 |
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis
|
He, Liyun
|
|
|
11 |
Suppl 1 |
p. 2121-2143
|
artikel
|
| 146 |
Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety
|
Ponzani, Paola
|
|
|
11 |
Suppl 1 |
p. 97-105
|
artikel
|
| 147 |
Switching to Degludec is Associated with Reduced Hypoglycaemia, Irrespective of Definition Used or Patient Characteristics: Secondary Analysis of the ReFLeCT Prospective, Observational Study
|
de Valk, Harold W.
|
|
|
11 |
Suppl 1 |
p. 2159-2167
|
artikel
|
| 148 |
Systemic Delivery of siRNA Specific for Silencing TLR4 Gene Expression Reduces Diabetic Cardiomyopathy in a Mouse Model of Streptozotocin-Induced Type 1 Diabetes
|
Zhang, Yuwei
|
|
|
11 |
Suppl 1 |
p. 1161-1173
|
artikel
|
| 149 |
Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2)
|
Ghosh, Sujoy
|
|
|
11 |
Suppl 1 |
p. 2257-2268
|
artikel
|
| 150 |
The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance
|
Li, Yu-peng
|
|
|
11 |
Suppl 1 |
p. 71-81
|
artikel
|
| 151 |
The Correlation Between RDW, MPV and Weight Indices After Metabolic Surgery in Patients with Obesity and DM/IGR: Follow-Up Observation at 12 Months
|
Zhou, Li
|
|
|
11 |
Suppl 1 |
p. 2269-2281
|
artikel
|
| 152 |
The Diagnostic Utility of VibraTip for Distal Symmetrical Polyneuropathy in Type 2 Diabetes Mellitus
|
Papanas, Nikolaos
|
|
|
11 |
Suppl 1 |
p. 341-346
|
artikel
|
| 153 |
The Do-It-Yourself Artificial Pancreas: A Comprehensive Review
|
Kesavadev, Jothydev
|
|
|
11 |
Suppl 1 |
p. 1217-1235
|
artikel
|
| 154 |
The Effect of Glucagon-Like Peptide-1 Receptor Agonists on Renal Outcomes in Type 2 Diabetes
|
Yin, Win L.
|
|
|
11 |
Suppl 1 |
p. 835-844
|
artikel
|
| 155 |
The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies
|
Evans, Mark
|
|
|
11 |
Suppl 1 |
p. 83-95
|
artikel
|
| 156 |
The Place of Sulfonylureas in the Evolving Landscape of Combination Therapy
|
Yu, Miao
|
|
|
11 |
Suppl 1 |
p. 23-28
|
artikel
|
| 157 |
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Baseline Patient-Reported Outcomes
|
Boye, Kristina S.
|
|
|
11 |
Suppl 1 |
p. 2383-2399
|
artikel
|
| 158 |
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
|
Vidal, Josep
|
|
|
11 |
Suppl 1 |
p. 509-521
|
artikel
|
| 159 |
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain
|
Vidal, Josep
|
|
|
11 |
Suppl 1 |
p. 509-521
|
artikel
|
| 160 |
Three European Retrospective Real-World Chart Review Studies to Determine the Effectiveness of Flash Glucose Monitoring on HbA1c in Adults with Type 2 Diabetes
|
Kröger, Jens
|
|
|
11 |
Suppl 1 |
p. 279-291
|
artikel
|
| 161 |
Télépied Study: A Single-Centre Trial in Diabetic Subjects Comparing Total Duration of Hospitalization Over a 1-Year Period Required for Complete Healing of a Foot Ulcer Using Telemedicine Management and a Referral Nurse Versus the Standard Care Pathway
|
Dardari, Dured
|
|
|
11 |
Suppl 1 |
p. 1419-1427
|
artikel
|
| 162 |
Treatment Options for MODY Patients: A Systematic Review of Literature
|
Delvecchio, Maurizio
|
|
|
11 |
Suppl 1 |
p. 1667-1685
|
artikel
|
| 163 |
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients With Type 2 Diabetes: PRONTO-T2D Subpopulation Analysis
|
Jinnouchi, Hideaki
|
|
|
11 |
Suppl 1 |
p. 2075-2088
|
artikel
|
| 164 |
Ultra-Rapid Lispro Efficacy and Safety Compared to Humalog® in Japanese Patients with Type 1 Diabetes: PRONTO-T1D Subpopulation Analysis
|
Miura, Junnosuke
|
|
|
11 |
Suppl 1 |
p. 2089-2104
|
artikel
|
| 165 |
Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review
|
Woo, Vincent
|
|
|
11 |
Suppl 1 |
p. 2539-2553
|
artikel
|
| 166 |
Usability of Nasal Glucagon Device: Partially Randomized Caregiver and Third-Party User Experience Trial with Simulated Administration at a Japanese Site
|
Aranishi, Toshihiko
|
|
|
11 |
Suppl 1 |
p. 197-211
|
artikel
|
| 167 |
Value of Capillary Glucose Profiles in Assessing Risk of Nocturnal Hypoglycemia in Type 1 Diabetes Based on Continuous Glucose Monitoring
|
Ling, Qing
|
|
|
11 |
Suppl 1 |
p. 915-925
|
artikel
|
| 168 |
Vildagliptin Versus α-Glucosidase Inhibitor as Add-On to Metformin for Type 2 Diabetes: Subgroup Analysis of the China Prospective Diabetes Study
|
Chen, Yulong
|
|
|
11 |
Suppl 1 |
p. 247-257
|
artikel
|
| 169 |
Why Do Falls and Lower Limb Fractures Occur More Frequently in the Diabetic Patient and How Can They Be Prevented?
|
Bell, David S. H.
|
|
|
11 |
Suppl 1 |
p. 1687-1694
|
artikel
|
Tijdschrift beschrijving